[1681]
Norfolk and Waveney Lung Cancer Support Group
[21,0 KB]
From [www.cancernw.com] Last viewed: 13.07.2004
lung
cancer
Norfolk and Waveney Lung Cancer Support Group
Did you know there is a local support group?
The Norfolk and Waveney Lung Cancer Support Group held its first meeting in May 2003.
The meeting is held at the Norfolk and Norwich Hospital and, following the good response to the first two meetings, it is intended to hold further meetings twice a year, in May and November.
What is the meeting about?
First of all ? it is your meeting. The morning is friendly and relaxed with the opportunity to meet people in similar situations. Health professionals have given talks on topics such as diet and cancer and breathlessness.
The Question and Answer session is very popular and gives you and your family the opportunity to tell us about your experiences (good and bad).
Past suggestions and comments have been used to improve ...
[1682]
Lung Cancer
[45,1 KB]
From [employees.oneonta.edu] Last viewed: 13.07.2004
lung
cancer
Biology 207 Biology of Cancer Spring 2004
Lecture 15: Lung Cancer
Reading: Page 92 of Scientific American issue, ?What you need to know about cancer ?.
Web sources: www.lungcancer.org ; www.cancerindex.org/geneweb/X1501.htm
www.rad.kume.edu/nucmed/clinical/pet_lung.htm
Lecture outline:
1. Causes of lung cancer
2. Lung cancer statistics
3. Diagnosis
4. Types of lung cancer /staging
5. Cancer genes associated with lung cancer
6. Treatment/prospects of survival
7. Lung as site of secondary tumors
Lecture:
1. Major causes of lung cancer :
cigarette smoking (85-90% of cases)
asbestos workers (3-4%)
chemicals (benzopyrene, chromium, nickel, arsenic)
radiation exposure ...
[1683]
LUNG CANCER
[103,2 KB]
From [www.cip-elsevier.com] Last viewed: 13.07.2004
Gemma Schaepman, Senior Account Manager
C.I.P. – Conference Information Publishing, P.O. Box 993, 1000 AZ Amsterdam, The Netherlands
Tel: (+31) 20 485 2930 Fax: (+31) 20 485 2940 E-mail: g.schaepman@elsevier.com
www.cip-elsevier.com
LUNG CANCER
Journal of the International Association
For the Study of Lung Cancer (IASLC)
EDITOR-IN CHIEF:
H.H. Hansen
Department of Oncology, The Finsen Institute
Righospitalet, Copenhagen, Denmark
ABSTRACTED/INDEXED IN:
Current Contents/Clinical Medicine; Excerpta Medica (EMBASE); Index
Medicus (MEDLINE); Oncology Information Service; SciSearch; Current
Awareness in Biological Services (CABS)
IMPACT FACTOR/RANKING:
2.451 43/114 Oncology
9/32 Respiratory Systems
SCOPE :
Lung Cancer aims to provide all members of the International Association
for the Study of Lung ...
[1684]
Gordon Stone Susan Vaughan Geoffrey Hulks Ruth Innes LUNG CANCER ...
[414,5 KB]
From [www.show.scot.nhs.uk] Last viewed: 13.07.2004
Recent changes in lung cancer
incidence for south Asians
Lucy K Smith, Michael D Peake, Johannes L Botha
In England, the incidence of lung cancer among south
Asians (Indian, Pakistani, and Bangladeshi) is much lower
than in the rest of the population.
1
In the UK, south Asian
population, however, it is the commonest cancer for men
and the second commonest for women.
2
We explored
trends in lung cancer incidence from 1990 to 1999 in
Leicester (22% of residents classified as south Asian in
1991 census).
Participants, methods, and results
We identified cases of lung cancer diagnosed in Leicester
residents between 1 January 1990 and 31 December 1999
from the Trent Cancer Registry. Ethnicity data were not
available for all patients, so we used software assessing
forename and surname to classify patients as ...
[1685]
Chemotherapy in Non-Small Cell Lung Cancer: An Update
[423,7 KB]
From [www.ctu.mrc.ac.uk] Last viewed: 13.07.2004
Chemotherapy in Non-Small Cell Lung Cancer :
An Update
A meta-analysis of randomised trials using individual patient
data
Protocol C
Comparison 3
Surgery + Radiotherapy vs Surgery +Radiotherapy + Adjuvant Chemotherapy
Conducted by
the Non-Small Cell Lung Cancer Collaborative Group (NSCLCCG)
May 2004
Page 2
Protocol C
surgery + radiotherapy vs surgery + radiotherapy + chemotherapy
NSCLC Collaborative Group
Secretariat
Comparisons 1, 2 & 7 please contact
Meta-analysis Group
MRC Clinical Trials Unit
222 Euston Road
London
NW1 2DA
UK
Fax:
+44 (0)20 7670 4816
Sarah Burdett
email: sb@ctu.mrc.ac.uk
tel:
+44 (0)20 7670 4722
Lesley Stewart
email: ls@ctu.mrc.ac.uk
tel:
+44 (0)20 7670 4724
Richard ...
[1686]
9 OUT OF 10 LUNG CANCER CASES ARE CAUSED BY SMOKING. NEUF CAS DE ...
[138,2 KB]
From [www.porcupinehu.on.ca] Last viewed: 13.07.2004
9 OUT OF 10 LUNG
CANCER CASES ARE
CAUSED BY SMOKING.
NEUF CAS DE CANCER
DU POUMON SUR DIX
SONT ATTRIBUABLES
À L'USAGE DU TABAC.
With funding from the
Government of Ontario
Grâce à un financement du
gouvernement de l'Ontario
Page 2
www.porcupinehu.on.ca
L’usage du tabac nuit au personnel de
l’industrie de l’accueil
Le saviez-vous?
- Les employés des bars et des tavernes ont des
taux plus élevés de cancer du poumon que tout
autre employé.
- La fumée non filtrée s’échappant de l’extrémité
d’une cigarette contient une plus forte
concentration de substances dangereuses que la
fumée inhalée par le fumeur. Bien entendu, les
fumeurs sont exposés aux deux types de fumée.
- S’il s’agit d’un établissement achalandé et que
les employés travaillent fort, ils inhaleront
encore plus de fumée secondaire ...
[1687]
Women and Lung Cancer: News You Can Use
[55,2 KB]
From [www2.mdanderson.org] Last viewed: 13.07.2004
OncoLog • February 2003
7
P H Y S I C I A N S : T H I S P A T I E N T I N F O R M A T I O N S H E E T I S Y O U R S T O C O P Y A N D P A S S O N T O P A T I E N T S .
For more information, contact
your physician or contact the
M. D. Anderson Information Line:
?
(800) 392-1611
within
the United States, or
?
(713) 792-6161 in Houston
and outside the United States.
February 2003
©2003 The University of Texas
M. D. Anderson Cancer Center
Women and Lung Cancer :
News You Can Use
Since 1950, the number of women
who die of lung cancer each year has
increased 600%, according to a 2001
Surgeon General’s report on “Women
and Smoking.” More than 22 million
women and 1.5 million adolescent girls
in the United States smoke cigarettes,
and the number of smokers is increasing ...
[1688]
P3090/Lung Cancer Report20 page
[142,7 KB]
From [www.cancercare.on.ca] Last viewed: 13.07.2004
Clinical Focus on Lung Cancer
A snapshot of lung cancer for Ontario health care providers and managers
Driving quality, accountability and innovation
throughout Ontario’s cancer system
Page 2
C
LINICAL
F
OCUS ON
L
UNG
C
ANCER
Prepared by:
Dr. W.K. (Bill) Evans
Chief Medical Officer and
Provincial Vice-President
Cancer Care Ontario
and
Chair, Lung Disease Site Group
With the Assistance of:
Dr. Terrence Sullivan
Deborah Fitzsimmons
Dr. Eric Holowaty
Alex Drossos
Dr. Anthony Whitton
Mark Gregus
Dr. Brent Zanke
Diane Nishri
Dr. Loraine D. Marrett
Saira Bahl
Ian Brunskill
Sherman Quan
Beth Theis
Bev Hess
May 2004
T
ABLE OF ...
[1689]
General Practitioner in Oncology Self-directed Learning Program ...
[110,6 KB]
From [www.cancercare.on.ca] Last viewed: 13.07.2004
General Practitioner in
Oncology Self-directed
Learning Program
LUNG CANCER
MODULE
Page 2
Lung Cancer Case Scenario 1
A 65-year-old man presents with a 6- week history of cough, progressive
SOB and a 20-pound weight loss. He has a 50-pack year smoking history
and his family doctor orders a chest x-ray and blood work.
The chest x-ray shows a left lower lobe mass. A CT scan of the thorax
shows mediastinal lymph nodes confined to the left hemithorax.
1. What tests are required to properly stage this patient?
2. Assuming his disease is confined to the chest, what stage is this man’s
small cell lung cancer ?
3. How does staging for small cell lung cancer differ from non-small cell
lung cancer ?
4. With respect to staging in small cell lung cancer , how would stage be
affected if the patient ...
[1690]
Non small-cell lung cancer, mesothelioma, and thymoma
[187,2 KB]
From [www.thymic.org] Last viewed: 13.07.2004
NON–SMALL-CELL LUNG CANCER , MESOTHELIOMA, AND THYMOMA
123
CHAPTER 7
Non–small-cell lung
cancer , mesothelioma,
and thymoma
Robert J. McKenna, Jr.,
MD
, Benjamin Movsas,
MD
, Dong M. Shin,
MD
,
and Fadlo R. Khuri,
MD
In the United States, lung cancer has been the leading cause of cancer death in
men for years, and since 1988, it has become the number-one cause of cancer
death in women. It is estimated that 171,900 new cases of lung cancer will be
diagnosed in 2003, and 157,200 deaths due to this disease will occur. This
exceeds the combined number of deaths from the second, third, and fourth
leading causes of cancer (breast, prostate, and colon cancer , respectively).
Lung cancer appears to develop from a stem cell that can differentiate along
multiple lines. Although ...
[1691]
LUNG CANCER MORTALITY IN A DISTRICT OF LA SPEZIA (ITALY) EXPOSED ...
[186,9 KB]
From [www.pensiero.it] Last viewed: 13.07.2004
Tumori, 90: 181-185, 2004
Introduction
In Italy, lung cancer is the leading cause of cancer
mortality in men and the third (after breast and intesti-
nal) in women, causing over 31,000 deaths in 1997
1
.
The mortality trend showed a nearly linear rise in males
until 1987-1988, followed by a drop of about 16% in
the 9 years thereafter, with age standardized rates rang-
ing from 60.3 to 50.6 per 100,000 inhabitants (stan-
dard: world population). In contrast, the corresponding
figures for females (7.9 per 100,000 inhabitants in
1997) have not displayed any clear decline in recent
years
1
.
Although cigarette smoking is known to be by far the
main factor responsible for the observed differences in
lung cancer occurrence among different populations
2
,
several epidemiologic studies have implicated outdoor
environmental ...
[1692]
Fact sheet-lung cancer (Page 2)
[737,7 KB]
From [www.brighamandwomens.org] Last viewed: 13.07.2004
M
ARY
H
ORRIGAN
C
ONNORS
C
ENTER
FOR
W
OMEN
’
S
H
EALTH AND
G
ENDER
B
IOLOGY
P
OLICY
I
SSUES IN
W
OMEN
’
S
H
EALTH
:
L
UNG
C
ANCER AND
S
MOKING
Lung cancer mortality rates among women have increased by 600% since 1950.
1
In 2001, lung cancer was the leading cause
of cancer death for women in Massachusetts, surpassing breast cancer , and accounting for 24% of all deaths. The lung cancer
mortality rate among women in Massachusetts increased from 43.3 per 100,000 in 1989 to 51.2 in 1998. Although the
mortality rate from lung ...
[1693]
Lung Cancer
[90,0 KB]
From [www.preventcancer.org] Last viewed: 13.07.2004
Lung
Cancer
Lung cancer is the leading cause of cancer deaths for both men and women. Death rates are
declining in men but continue to increase in women. Tobacco use is the most important risk
factor for lung cancer .
PREVENTION
• Don’t use tobacco in any form
• If you use tobacco, quit
• Create smoke-free environments in your
community
RISKS
• People who use tobacco in any form
• People who have had exposure to
substances such as arsenic, radon and
asbestos
• People whose occupation exposes them
to radiation
• People exposed to second-hand smoke
• All people exposed to air pollution and
environmental smoke are at some risk
SYMPTOMS
In the early stages, there may be no symptoms
• Persistent
cough
• Sputum (spit) streaked with blood
• Chest
pain
• Recurring pneumonia or bronchitis ...
[1694]
Lung Cancer
[40,5 KB]
From [www.stlukesonline.org] Last viewed: 13.07.2004
Lung Cancer
When it comes to cancer , knowledge is good medicine.
More men and women die of lung cancer than any other type of cancer in the United States. In
recent years, more women have died from lung cancer than even breast cancer , because more
women continue to smoke.
Cigarette smoking is by far the most important preventable cause of lung cancer . Tobacco is
linked to 87 percent of all lung cancer cases. Other factors include exposure to:
• Industrial substances (such as chemicals and asbestos)
• Radiation exposure from occupational, medical and environmental sources
• Air pollution
• Radon exposure
People who smoke cigarettes and have exposure to other risk factors have an even greater
chance of developing cancer of the lung . Second-hand tobacco smoke increases lung cancer risk
for nonsmokers. The good news is studies show that ...
[1695]
Fact sheet-lung cancer (Page 2)
[737,7 KB]
From [www.brighamandwomens.org] Last viewed: 13.07.2004
M
ARY
H
ORRIGAN
C
ONNORS
C
ENTER
FOR
W
OMEN
’
S
H
EALTH AND
G
ENDER
B
IOLOGY
P
OLICY
I
SSUES IN
W
OMEN
’
S
H
EALTH
:
L
UNG
C
ANCER AND
S
MOKING
Lung cancer mortality rates among women have increased by 600% since 1950.
1
In 2001, lung cancer was the leading cause
of cancer death for women in Massachusetts, surpassing breast cancer , and accounting for 24% of all deaths. The lung cancer
mortality rate among women in Massachusetts increased from 43.3 per 100,000 in 1989 to 51.2 in 1998. Although the
mortality rate from lung ...
[1696]
Lung Cancer - Frequently Asked Questions
[94,7 KB]
From [www.4woman.gov] Last viewed: 13.07.2004
Frequently Asked Questions about Lung Cancer
What is lung cancer ?
Cancer is a disease in which certain body cells don’t function right, divide very fast, and produce too
much tissue that forms a tumor. The lungs, a pair of sponge-like, cone-shaped organs, are part of the
body’s respiratory system. When we breathe in, the lungs take in oxygen, which our cells need to live
and carry out their normal functions. When we breathe out, the lungs get rid of carbon dioxide, which is
a waste product of the body's cells. Cancers that begin in the lungs are divided into two major types,
non-small cell lung cancer and small cell lung cancer , depending on how the cells look under a
microscope. Each type of lung cancer grows and spreads in different ways and is treated differently.
Why should I be concerned about lung cancer ?
Did you know that lung cancer ...
[1697]
Lung Cancer Miscellaneous Clinical Trials
[228,4 KB]
From [www.mc.vanderbilt.edu] Last viewed: 13.07.2004
VICC THO 0214
Phase II: OSI-
774 (Tarceva) in
Pts with
Advanced BAC
Bronchioloalveolar
1st or 2nd
Line
1st or 2nd
Line
Mesothelioma
Lung Cancer
Miscellaneous
Clinical Trials
VICC SAR 0269
Phase II: SDX-102 for
NSCLC pts with MTAP-
deficient cancer
K E Y
Pending
Suspended
Open
Revised
Team Leader Signature and Date
Revised
5/17/04
[1698]
Strongest Study Yet Links Small Pollution Particles to Lung Cancer
[61,7 KB]
From [www.seedcoalition.org] Last viewed: 13.07.2004
FOR IMMEDIATE RELEASE
CONTACT Karen Hadden
Tuesday, March 5, 2002
512-797-8481
Strongest Study Yet Links Small Pollution
Particles to Lung Cancer
Shows the Need to Clean up Power Plant Sulfur and the
Skies Over Big Bend National Park
A study released today by the Journal of the American Medical Association shows that exposure to air pollution
with high levels of tiny particles of dust and soot significantly increases the risk of dying from lung cancer and
heart disease. “The new study provides the strongest data yet that exposure to fine particles (PM
2.5
)
is linked with
lung cancer and cardiopulmonary mortality. Particle air pollution is common in many U.S. cities, and is a large part
of the haze that obscures vistas in national parks, such as Big Bend in Texas,” noted Karen Hadden, Clean Air
Coordinator for the SEED (Sustainable ...
[1699]
EGFR Mutations in Lung Cancer: Correlation with Clinical Response ...
[358,4 KB]
From [www-biology.ucsd.edu] Last viewed: 13.07.2004
/ www.sciencexpress.org / 29 April 2004 / Page 1/ 10.1126/science.1099314
Receptor tyrosine kinase genes were sequenced in non-
small cell lung cancer (NSCLC) and matched normal
tissue. Somatic mutations of the epidermal growth factor
receptor gene EGFR were found in 15 of 58 unselected
tumors from Japan and 1 of 61 from the United States.
Treatment with the EGFR kinase inhibitor gefitinib
(Iressa) causes tumor regression in some patients with
NSCLC, more frequently in Japan. EGFR mutations were
found in additional lung cancer samples from U.S.
patients who responded to gefitinib therapy and in a lung
adenocarcinoma cell line that was hypersensitive to
growth inhibition by gefitinib, but not in gefitinib-
insensitive tumors or cell lines. These results suggest that
EGFR mutations may predict sensitivity to gefitinib.
Protein kinase activation by somatic ...
[1700]
USING SPLINES TO ANALYSE THE RADON EXPOSURE-TIME- LUNG CANCER RISK ...
[44,1 KB]
From [www.sante.univ-nantes.fr] Last viewed: 13.07.2004
Rogel, A
1
USING SPLINES TO ANALYSE THE RADON EXPOSURE-TIME-
LUNG CANCER RISK IN URANIUM MINER’S COHORT
Author's name(s) : Rogel A.*, Fouillet A., Laurier D., Tirmarche M.
Affiliation(s) : Laboratoire d’Epidémiologie, Institut de Radioprotection et Sûreté Nucléaire
BP n°17, 92262 Fontenay-aux-Roses Cedex. France.
Email: agnes.rogel@irsn.fr
Phone : 33-1-58-35-74-27; Fax: 33-1-46-57-03-86
Topic area : Statistics in Cancer Research
Keywords : Radon, Exposure-time-risk, B-splines
Abstract
Research objectives
Numerous studies have shown a significant increase in death from lung cancer related to
radon exposure among uranium miner’s
1
. Uncertainty still remains concerning the exposure-
risk relationship at low levels, in part due to imprecise knowledge of the effect of time-
dependent modifying factors, such as time since exposure ...
[1701]
Tarceva drug extends life in lung cancer patients Louvre officials ...
[395,2 KB]
From [www.myanmargeneva.org] Last viewed: 13.07.2004
THE NEW LIGHT OF MYANMAR Thursday, 29 April, 2004 13
Tarceva drug extends life in lung cancer
patients
Z
URICH
/N
EW
Y
ORK
, 28 April — An experimental lung cancer drug extended
patients’ life-expectancy by a third in a late-stage clinical trial reported on Monday,
a potential breakthrough that pumped adrenalin into biotechnology shares.
The drug, Tarceva, which
is being developed by OSI
Pharmaceuticals Inc.,
Genentech Inc. and Roche
Holding AG, was tested in
patients who had failed to
respond to chemotherapy.
“It’s a giant leap forward
for lung cancer patients,”
said Dr. Roy Herbst, chief of
the lung cancer division at
the University of Texas MD
Anderson Cancer Center in
Houston.
About 170,000 lung can-
cer sufferers die in the United
States ...
[1702]
Spiral CT for Lung Cancer Screening
[179,5 KB]
From [www.cigna.com] Last viewed: 13.07.2004
C
IGNA
H
EALTH
C
ARE
C
OVERAGE
P
OSITION
Subject:
Spiral Computed Tomography (CT) For Lung Cancer Screening
Coverage Position Number: 0007
Effective Date: 2/15/2004
Table of Contents:
Related Coverage Positions:
Coverage Position.. 1
General Background . 1
Coding/Billing Information .. 2
References. 2
INSTRUCTIONS FOR USE
Coverage Positions are intended to supplement certain standard CIGNA HealthCare benefit plans. Please note, the terms of a
participant’s particular benefit plan document [Group Service Agreement (GSA), Evidence of Coverage, Certificate of Coverage,
Summary Plan Description (SPD) or similar plan document] may differ significantly from the standard benefit plans ...
[1703]
Lung Cancer Screening with Sputum Cytologic Examination, Chest ...
[305,7 KB]
From [www.ahrq.gov] Last viewed: 13.07.2004
Screening for lung cancer is not currently
recommended by any major medical professional
organization. The U.S. Preventive Services Task
Force (USPSTF) gave lung cancer screening a “D”
recommendation in both 1985 and 1996, meaning
that there were fair-quality data to recommend
against screening for lung cancer
1
based largely on 3
negative trials conducted in the United States in the
1970s. Since the last Task Force review, several new
studies of lung cancer screening have been reported,
and greater attention has been directed toward the
limitations of existing literature. This review was
conducted to aid the current USPSTF in updating
its lung cancer screening recommendation.
Lung cancer is the leading cause of cancer -related
death among men and women in the United States;
in 2003, approximately 171,900 new cases and
157,200 ...
[1704]
The Impact of PET on the Management of Lung Cancer: The Referring ...
[84,4 KB]
From [www.stanfordhospital.com] Last viewed: 13.07.2004
The Impact of PET on the Management of Lung
Cancer : The Referring Physician’s Perspective
Marc A. Seltzer, MD
1
; Cecelia S. Yap, BS
1
; Daniel H. Silverman, MD, PhD
1
; Joubin Meta, BS
1
;
Christiaan Schiepers, MD, PhD
1
; Michael E. Phelps, PhD
1
; Sanjiv S. Gambhir, MD, PhD
1
; Jyotsna Rao, MD
2
;
Peter E. Valk, MD
2
; and Johannes Czernin, MD
1
1
Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Clinic/Nuclear Medicine,
UCLA School of Medicine, Los Angeles, California; and
2
Northern California PET Imaging Center, Sacramento, California
18
F-FDG PET is a molecular whole-body imaging modality that
is increasingly being used for diagnosing, staging, and restaging
cancer ...
[1705]
072700 Preoperative Staging of Non Small-Cell Lung Cancer
[254,5 KB]
From [www.stanfordhospital.com] Last viewed: 13.07.2004
254
·
Ju l y 2 7 , 2 0 0 0
The Ne w E n g l a nd Jo u r n a l o f Me d ic i ne
PREOPERATIVE STAGING OF NON–SMALL-CELL LUNG CANCER
WITH POSITRON-EMISSION TOMOGRAPHY
R
EMGE
M. P
IETERMAN
, M.D., J
OHN
W.G.
VAN
P
UTTEN
, M.D., J
ACOBUS
J. M
EUZELAAR
, M.D., E
DUARD
L. M
OOYAART
, M.D.,
W
ILLEM
V
AALBURG
, P
H
.D., G
ERARD
H. K
OËTER
, M.D., V
ACLAV
F
IDLER
, P
H
.D., J
AN
P
RUIM
, M.D.,
AND
H
ARRY
J.M. G
ROEN
, M.D.
A
BSTRACT
Background
Determining the stage of non–small-
...
[1706]
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Lung Cancer
[65,6 KB]
From [www.mass.gov] Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES
Source: Community Assessment Unit, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health
December, 2002
Lung Cancer
Lung cancer generally arises in the epithelial tissue of the lung . Several different histologic or
cell types of lung cancer have been observed. The various types of lung cancer occur in different
regions of the lung and each type is associated with slightly different risk factors (Blot and
Fraumeni 1996). The most common type of lung cancer in the United States today is
adenocarcinoma which accounts for about 40% of all lung cancers (ACS, 2000). The greatest
established risk factor for all types of lung cancer is cigarette smoking, followed by occupational
and environmental exposures.
The incidence of lung cancer increases sharply ...
[1707]
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Lung Cancer
[86,6 KB]
From [www.mass.gov] Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES
Lung Cancer
Lung cancer generally arises in the epithelial tissue of the lung . Several different histologic or
cell types of lung cancer have been observed. The various types of lung cancer occur in different
regions of the lung and each type is associated with slightly different risk factors (Blot and
Fraumeni 1996). The most common type of lung cancer in the United States today is
adenocarcinoma which accounts for about 40% of all lung cancers (ACS, 2000). The greatest
established risk factor for all types of lung cancer is cigarette smoking, followed by occupational
and environmental exposures.
The incidence of lung cancer increases sharply with age peaking at about age 60 or 70. Lung
cancer is very rare in people under the age of 40. The incidence is greater among men than ...
[1708]
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES Lung Cancer
[68,1 KB]
From [www.mass.gov] Last viewed: 13.07.2004
RISK FACTOR INFORMATION FOR SELECTED CANCER TYPES
Source: Community Assessment Unit, Bureau of Environmental Health Assessment, Massachusetts Department of Public Health
July, 2001
Lung Cancer
Lung cancer generally arises in the epithelial tissue of the lung . Several different histologic or
cell types of lung cancer have been observed. The various types of lung cancer occur in different
regions of the lung and each type is associated with slightly different risk factors (Blot and
Fraumeni 1996). The most common type of lung cancer in the United States today is
adenocarcinoma which accounts for about 40% of all lung cancers (ACS, 2000). The greatest
established risk factor for all types of lung cancer is cigarette smoking, followed by occupational
and environmental exposures.
The incidence of lung cancer increases sharply with age peaking ...
[1709]
Lung Cancer Screening
[207,7 KB]
From [www.ahrq.gov] Last viewed: 13.07.2004
Summary of
Recommendation
The U.S. Preventive Services Task Force
(USPSTF) concludes that the evidence is
insufficient to recommend for or against screening
asymptomatic persons for lung cancer with either
low dose computerized tomography (LDCT),
chest x-ray (CXR), sputum cytology, or a
combination of these tests. I recommendation.
The USPSTF found fair evidence that screening
with LDCT, CXR, or sputum cytology can detect lung
cancer at an earlier stage than lung cancer would be
detected in an unscreened population; however, the
USPSTF found poor evidence that any screening
strategy for lung cancer decreases mortality. Because
of the invasive nature of diagnostic testing and the
possibility of a high number of false-positive tests in
certain populations, there is potential for significant
harms from screening. Therefore, the ...
[1710]
Lung Cancer in Kalamazoo County
[137,5 KB]
From [www.kalcounty.com] Last viewed: 13.07.2004
Kalamazoo County Human Services Department
Volume I ? Number 3
www.kalcounty.com July
2002
Lung Cancer in Kalamazoo County
? In 1999, 128 cases of lung cancer
were diagnosed in Kalamazoo County
residents (Table 1). The average
number of cases remained stable from
1990-94 (134.6 cases) to 1995-99 (135
cases).
? During much of the 1990s lung
cancer incidence rates in the county
were lower than the state (Figure 1).
The 1995-99 average county rate was
6.7 compared to the MI rate of 7.5 per
10,000.
? Ninety-seven deaths in the county
were attributed to lung cancer during
2000 accounting for 25% of all county
cancer related deaths (Table 1).
? In 2000 the lung cancer mortality
rate in the county was 4.7 per 10,000
compared to the Michigan rate ...